Postexposure prophylaxis of breastfeeding HIV-Exposed Infants with Antiretroviral Drugs to Age 14 Weeks: Updated efficacy results of the PEPI-Malawi Trial

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue 4, 2011, Pages 319-325

  Taha, Taha E ^a   Li, Qing ^b   Hoover, Donald R ^c   Mipando, Linda ^d   Nkanaunena, Kondwani ^d   Thigpen, Michael C ^e   Taylor, Allan ^e   Kumwenda, Johnstone ^f   Fowler, Mary Glenn ^g   Mofenson, Lynne M ^h   Kumwenda, Newton I ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f UNIVERSITY OF MALAWI   (Malawi)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

breastfeeding; infant postexposure prophylaxis; motherto child transmission of HIV; PEPI Malawi

Indexed keywords

HEMOGLOBIN; NEVIRAPINE; ZIDOVUDINE;

ADULT; ARTICLE; BREAST FEEDING; CONTROLLED STUDY; DRUG EFFICACY; DRUG EXPOSURE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION PREVENTION; INFECTION RATE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALAWI; MALE; MORTALITY; NEUTROPENIA; POSTNATAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SIDE EFFECT; SINGLE DRUG DOSE; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; BREAST FEEDING; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALAWI; MALE; NEVIRAPINE; POST-EXPOSURE PROPHYLAXIS; ZIDOVUDINE;

EID: 79959929512     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318217877a     Document Type: Article

References (17)

1. Kumwenda NI, Hoover DR, Mofenson LM, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV infection. N Engl J Med. 2008;359: 119-129. (Pubitemid 351962035)
2. Taha TE, Kumwenda J, Cole SR, et al. Postnatal HIV-1 transmission after cessation of extended infant antiretroviral prophylaxis and effect of maternal HAART. J Infect Dis. 2009;200:1490-1497.
3. National Institutes of Health. Division of AIDS table for grading the severity of adult and pediatric adverse events. Version 1.0, December 2004; Clarification August 2009. Available at: http://www.docstoc.com/docs/23913612/ DAIDS-Toxicity-Table. Accessed August 2, 2010.
4. Lidstrom J, Li Q, Hoover DR, et al. Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero. AIDS. 2010;24:381-386.
5. Kafulafula G, Hoover DR, Taha TE, et al. Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-infected women in Malawi. J Acquir Immune Defic Syndr. 2010;53:6-13.
6. Onyango-Makumbi C, Bagenda D, Mwatha A, et al. Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: findings from two perinatal HIV prevention trials in Kampala, Uganda. J Acquir Immune Defic Syndr. 2010;53:20-27.
7. Homsy J, Moore D, Barasa A, et al. Breastfeeding, mother-to-child transmission, and mortality among infants born to HIV-infected women on highly active antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr. 2010;53:28-35.
8. Creek TL, Kim A, Lu L, et al. Hospitalization and mortality among primarily non-breastfed children during a large outbreak of diarrhea and malnutrition in Botswana, 2006. J Acquir Immune Defic Syndr. 2010;53: 14-19.
9. Chasela CS, Hudgens MG, Jamieson, et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med. 2010;362: 2271-2281.
10. Shapiro RL, Hughes MD, Ogwu A, et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med. 2010;362: 2282-2294.
11. Mofenson LM. Protecting the next generation-eliminating perinatal HIV-1 infection. N Engl J Med. 2010;362:2316-2318.
12. World Health Organization. New recommendations: preventing motherto-child transmission. Available at: http://www.who.int/hiv/pub/mtct/mtct-key-mess.pdf. Accessed April 8, 2011. Accepted 2009.
13. de Vincenzi, Kesho Bora Study Group. Triple-antiretroviral (ARV) prophylaxis during pregnancy and breastfeeding compared to short-ARV prophylaxis to prevent, other-to-child transmission of HIV-1 (MTCT): the Kesho Bora randomized controlled clinical trial in five sites in Burkina Faso, Kenya and South Africa. Presented at: 5th International Conference on HIV Pathogenesis Treatment and Prevention; July 19-22, 2009; Cape Town, South Africa. Abstract # LBPEC01.
14. Miotti PM, Taha TET, Kumwenda NI, et al. HIV transmission through breastfeeding, a study in Malawi. JAMA. 1999;282:744-749. (Pubitemid 29404380)
15. Nduati R, John G, Mbori-Ngacha D, et al. Breastfeeding and formula feeding on transmission of HIV-1. A randomized clinical trial. JAMA. 2000;283:1167-1174. (Pubitemid 30126605)
16. Semba RD, Kumwenda N, Hoover DR, et al. Human immunodeficiency virus load and breastmilk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis. 1999;180:93-98. (Pubitemid 29293922)
17. Gaur AH, Dominguez KL, Kalish ML, et al. Practice of feeding premasticated food to infants: a potential risk factor for HIV transmission. Pediatr. 2009;124:658-666.